Literature DB >> 2848821

Up-regulation of high density lipoprotein receptor activity by gamma-interferon associated with inhibition of cell proliferation.

M J Oppenheimer1, J F Oram, E L Bierman.   

Abstract

High density lipoprotein (HDL) binds to cell surface receptors and promotes selective removal of excess cholesterol from intracellular pools. The activity of this receptor is up-regulated when cells become loaded with cholesterol, but the relative degree of up-regulation depends on the growth state of the cells. The current study demonstrates that treatment of proliferating fibroblasts with gamma-interferon (IFN) increases the activity of the HDL receptor in association with a decrease in the rate of cell proliferation. Addition of IFN during the growth phase reduced the number of cells but had little effect on total cell protein, indicating that IFN inhibited cell proliferation but produced larger cells. IFN treatment increased the number of high affinity receptors for HDL on the surface of cholesterol-loaded fibroblasts, whether receptor binding was expressed per cell or per unit of cell surface area, cell protein, or cell cholesterol. IFN treatment also appeared to increase the amount of 110-kDa HDL binding protein in fibroblast membranes that has been postulated to represent the HDL receptor molecule. The IFN-induced increase in HDL receptor activity was associated with an enhanced ability of HDL3 to remove cholesterol from intracellular pools. These results are consistent with the hypothesis that inhibition of cell proliferation increases HDL receptor-mediated transport of excess cholesterol from cells, possibly to rid cells of cholesterol that accumulates in response to a reduced rate of membrane synthesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848821

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Characterization and isolation of a high-density-lipoprotein-binding protein from bovine corpus luteum plasma membrane.

Authors:  K Ferreri; K M Menon
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

2.  High glucose levels do not directly impair cellular binding of HDL3 or HDL-mediated efflux of cholesterol from human skin fibroblasts.

Authors:  P B Duell; E L Bierman
Journal:  Acta Diabetol       Date:  1991       Impact factor: 4.280

3.  Characterization and purification of proteins which bind high-density lipoprotein. A putative cell-surface receptor.

Authors:  H M Bond; G Morrone; S Venuta; K E Howell
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

4.  Lipid utilization by human lymphocytes is correlated with high-density-lipoprotein binding site activity.

Authors:  Q Xu; G Jürgens; L A Huber; G Böck; H Wolf; G Wick
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

5.  Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms.

Authors:  M Walter; H Reinecke; U Gerdes; J R Nofer; G Höbbel; U Seedorf; G Assmann
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

6.  Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.

Authors:  G A Francis; R H Knopp; J F Oram
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  Induction of sustained expression of proto-oncogene c-fms by platelet-derived growth factor, epidermal growth factor, and basic fibroblast growth factor, and its suppression by interferon-gamma and macrophage colony-stimulating factor in human aortic medial smooth muscle cells.

Authors:  T Inaba; T Gotoda; K Harada; M Shimada; J Ohsuga; S Ishibashi; Y Yazaki; N Yamada
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

8.  Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130).

Authors:  S Dessí; B Batetta; C Anchisi; P Pani; P Costelli; L Tessitore; F M Baccino
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.